AU2003215524A1 - Pharmaceutical compositions comprising mannose binding lectin - Google Patents
Pharmaceutical compositions comprising mannose binding lectinInfo
- Publication number
- AU2003215524A1 AU2003215524A1 AU2003215524A AU2003215524A AU2003215524A1 AU 2003215524 A1 AU2003215524 A1 AU 2003215524A1 AU 2003215524 A AU2003215524 A AU 2003215524A AU 2003215524 A AU2003215524 A AU 2003215524A AU 2003215524 A1 AU2003215524 A1 AU 2003215524A1
- Authority
- AU
- Australia
- Prior art keywords
- mbl
- pharmaceutical compositions
- binding lectin
- compositions
- variants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000009112 Mannose-Binding Lectin Human genes 0.000 title abstract 11
- 108010087870 Mannose-Binding Lectin Proteins 0.000 title abstract 11
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200200414 | 2002-03-15 | ||
| DKPA200200414 | 2002-03-15 | ||
| PCT/DK2003/000179 WO2003077937A1 (en) | 2002-03-15 | 2003-03-14 | Pharmaceutical compositions comprising mannose binding lectin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003215524A1 true AU2003215524A1 (en) | 2003-09-29 |
Family
ID=27763313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003215524A Abandoned AU2003215524A1 (en) | 2002-03-15 | 2003-03-14 | Pharmaceutical compositions comprising mannose binding lectin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7462596B2 (enExample) |
| EP (1) | EP1344533B1 (enExample) |
| JP (1) | JP2005526084A (enExample) |
| CN (1) | CN1652813A (enExample) |
| AT (1) | ATE337014T1 (enExample) |
| AU (1) | AU2003215524A1 (enExample) |
| DE (1) | DE60307701T2 (enExample) |
| DK (1) | DK1344533T3 (enExample) |
| ES (1) | ES2271515T3 (enExample) |
| PT (1) | PT1344533E (enExample) |
| WO (1) | WO2003077937A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1412384T3 (da) | 2001-06-28 | 2008-04-28 | Novo Nordisk As | Stabil formulering af modificeret GLP-1 |
| GB0222014D0 (en) * | 2002-09-23 | 2002-10-30 | Leuven K U Res & Dev | Mannan-binding lectin |
| PL1633391T3 (pl) | 2003-06-03 | 2012-03-30 | Novo Nordisk As | Stabilizowane farmaceutycznie kompozycje peptydowe |
| BRPI0410972C1 (pt) | 2003-06-03 | 2021-05-25 | Novo Nordisk As | método para aumentar a vida de armazenagem de uma composição farmacêutica, composição farmacêutica, e, método para tratamento de hiperglicemia |
| CN104826116A (zh) | 2003-11-20 | 2015-08-12 | 诺沃挪第克公司 | 对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂 |
| US7335633B2 (en) * | 2004-01-12 | 2008-02-26 | Cornell Research Foundation, Inc. | Detecting recurrent vulvovaginal candidiasis or vulvar vestibulitis syndrome and method for treating same |
| EP1618887A1 (en) * | 2004-07-12 | 2006-01-25 | UMC Utrecht Holding B.V. | Clearance of polyols from the body |
| US8710181B2 (en) | 2004-08-31 | 2014-04-29 | Novo Nordisk A/S | Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins |
| RU2413530C9 (ru) | 2004-11-12 | 2021-05-18 | Ново Нордиск А/С | Стабильные препараты инсулинотропных пептидов |
| CN101094651B (zh) * | 2004-12-30 | 2011-03-09 | 多贝尔有限公司 | 含有胶原凝集素家族蛋白质或者其变体的喷雾干燥的组合物和其制备方法 |
| CN101193651A (zh) * | 2005-04-11 | 2008-06-04 | 内蒂穆恩公司 | 甘露聚糖结合凝集素(mbl)在治疗与癌症相关的免疫削弱的病症中的用途 |
| TW200727900A (en) * | 2005-07-27 | 2007-08-01 | Yakult Honsha Kk | Aqueous solution preparation containing camptothecins |
| EP2004850A2 (en) * | 2006-03-08 | 2008-12-24 | Universitair Medisch Centrum Utrecht | Interfering in activation of an immune cell by influencing interaction of lair and collagen. |
| HUE027443T2 (en) * | 2007-09-10 | 2016-10-28 | Boston Biomedical Inc | A novel class of Stat3 pathway inhibitors and tumor stem cell inhibitors |
| GB0821806D0 (en) * | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| CN107513103A (zh) * | 2009-07-17 | 2017-12-26 | 丹麦国家医院 | 作为补体激活的抑制剂的masp同种型 |
| WO2011090954A2 (en) | 2010-01-19 | 2011-07-28 | President And Fellows Of Harvard College | Engineered opsonin for pathogen detection and treatment |
| CN103025159A (zh) | 2010-03-19 | 2013-04-03 | 波士顿生物医学公司 | 靶向癌症干细胞的新方法 |
| EP3081937B1 (en) | 2011-07-18 | 2019-11-13 | President and Fellows of Harvard College | Engineered microbe-targeting molecules and uses thereof |
| AU2013225823A1 (en) | 2012-02-29 | 2014-09-18 | President And Fellows Of Harvard College | Rapid antibiotic susceptibility testing |
| CN118924900A (zh) * | 2012-06-18 | 2024-11-12 | 奥默罗斯公司 | 抑制masp-1和/或masp-2和/或masp-3的组合物和方法 |
| WO2014144325A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Methods and compositions for improving detection and/or capture of a target entity |
| JP6433085B2 (ja) | 2013-04-09 | 2018-12-05 | ボストン バイオメディカル， インコーポレイテッド | がんの処置に使用するための２−アセチルナフト［２，３−ｂ］フラン−４，９−ジオン |
| US9988617B2 (en) | 2013-05-21 | 2018-06-05 | President And Fellows Of Harvard College | Engineered heme-binding compositions and uses thereof |
| WO2015095604A2 (en) | 2013-12-18 | 2015-06-25 | President And Fellows Of Harvard College | Methods and assays relating to circulating tumor cells |
| WO2017024114A1 (en) | 2015-08-06 | 2017-02-09 | President And Fellows Of Harvard College | Improved microbe-binding molecules and uses thereof |
| US11299469B2 (en) | 2016-11-29 | 2022-04-12 | Sumitomo Dainippon Pharma Oncology, Inc. | Naphthofuran derivatives, preparation, and methods of use thereof |
| WO2018213424A1 (en) | 2017-05-17 | 2018-11-22 | Boston Biomedical, Inc. | Methods for treating cancer |
| EP3474820B1 (en) | 2017-08-24 | 2024-02-07 | Novo Nordisk A/S | Glp-1 compositions and uses thereof |
| CN110755601B (zh) * | 2019-10-31 | 2023-06-23 | 云南康洲生物科技有限公司 | 一种治疗hiv/aids免疫重建缺陷的芸豆凝集素植物药组合物和制备方法及其应用 |
| PE20230819A1 (es) | 2020-02-18 | 2023-05-19 | Novo Nordisk As | Composiciones y usos de glp-1 |
| CA3232962A1 (en) * | 2021-10-01 | 2023-04-06 | Uros Andjelkovic | Carbohydrate binding polypeptide of savalia savaglia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4707231B2 (ja) * | 1998-06-10 | 2011-06-22 | スタテンズ セーラム インスティテュート | マンナン結合レクチンを製造するための精製方法及びｍｂｌ医薬品 |
| NZ509089A (en) * | 1998-06-10 | 2002-10-25 | Statens Seruminstitut | Affinity chromatography purification for production of mannan-binding lectin |
| US6297024B1 (en) * | 1998-10-15 | 2001-10-02 | Cell Activation, Inc. | Methods for assessing complement activation |
| AU781135B2 (en) * | 1999-05-14 | 2005-05-05 | Thomas Vorup Jensen | Recombinant human mannan-binding lectin |
| US7211396B2 (en) * | 2002-04-18 | 2007-05-01 | Antibodyshop A/S | Antibody pairs and kits for immunochemical determination of mannan-binding lectin |
-
2003
- 2003-03-14 JP JP2003575990A patent/JP2005526084A/ja active Pending
- 2003-03-14 WO PCT/DK2003/000179 patent/WO2003077937A1/en not_active Ceased
- 2003-03-14 PT PT03388016T patent/PT1344533E/pt unknown
- 2003-03-14 AT AT03388016T patent/ATE337014T1/de not_active IP Right Cessation
- 2003-03-14 DE DE60307701T patent/DE60307701T2/de not_active Expired - Fee Related
- 2003-03-14 AU AU2003215524A patent/AU2003215524A1/en not_active Abandoned
- 2003-03-14 DK DK03388016T patent/DK1344533T3/da active
- 2003-03-14 US US10/388,322 patent/US7462596B2/en not_active Expired - Fee Related
- 2003-03-14 ES ES03388016T patent/ES2271515T3/es not_active Expired - Lifetime
- 2003-03-14 CN CNA038105802A patent/CN1652813A/zh active Pending
- 2003-03-14 EP EP03388016A patent/EP1344533B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1652813A (zh) | 2005-08-10 |
| EP1344533A1 (en) | 2003-09-17 |
| PT1344533E (pt) | 2007-01-31 |
| DE60307701T2 (de) | 2007-10-11 |
| DE60307701D1 (de) | 2006-10-05 |
| JP2005526084A (ja) | 2005-09-02 |
| DK1344533T3 (da) | 2007-01-08 |
| ATE337014T1 (de) | 2006-09-15 |
| EP1344533B1 (en) | 2006-08-23 |
| ES2271515T3 (es) | 2007-04-16 |
| US20040006009A1 (en) | 2004-01-08 |
| WO2003077937A1 (en) | 2003-09-25 |
| US7462596B2 (en) | 2008-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003215524A1 (en) | Pharmaceutical compositions comprising mannose binding lectin | |
| IL203923A (en) | Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds | |
| HK81397A (en) | Pharmaceutical compositions containing benzenesulphonamides | |
| HUP0401241A3 (en) | Novel cyclohexyl sulphones, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303148A3 (en) | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation | |
| CA2436540A1 (en) | Pharmaceutical compositions based on anticholinergics and corticosteroids | |
| CA2431565A1 (en) | Pharmaceutical compositions based on anticholinergics and ciclesonide | |
| CZ20012028A3 (cs) | Nové N-substituované 2-kyanopyrrolidiny, farmaceutický prostředek, který je obsahuje a jejich použití jako léčivo | |
| CA2534798A1 (en) | Thiazole derivatives as cannabinoid receptor modulators | |
| HUP0400246A3 (en) | 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use | |
| HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
| IL204947A0 (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them | |
| CA2338600A1 (en) | Novel thiazolopyrimidine compounds | |
| HUP0103063A3 (en) | Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| IL171914A0 (en) | Variants of il-18bp, their preparation and pharmaceutical compositions containing them | |
| AU2003202719A1 (en) | Novel antibacterial compounds:process for their preparation and pharmaceutical compositions containing them. | |
| CA2388910A1 (en) | Antimicrobial activity of the first cationic cluster of human lactoferrin | |
| AU2002348829A1 (en) | Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| WO2003020963A3 (en) | Proteins in type 2 diabetes | |
| HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
| WO2003050067A3 (fr) | Analogues de la vitamine d | |
| HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
| WO2004031222A3 (en) | Dna vaccine encoding at least two nonstructural early proteins of papillomavirus | |
| WO2002070537A3 (en) | Fusidic acid derivatives | |
| MXPA03010259A (es) | Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |